🇺🇸 FDA
Patent

US 9073863

Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasing ion transport and uses thereof

granted A61KA61K31/44A61P

Quick answer

US patent 9073863 (Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasing ion transport and uses thereof) held by The Regents of the University of California expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
57
CPC classes
A61K, A61K31/44, A61P, A61P11/00